Related Experiment Videos
Inhibiting bacterial fatty acid synthesis.
Yong-Mei Zhang1, Stephen W White, Charles O Rock
1Department of Infectious Diseases, St. Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105-2794, USA.
The Journal of Biological Chemistry
|May 2, 2006
Summary
Novel antibacterial drugs can be developed by targeting enzymes in the type II fatty acid synthase pathway. Structural data for these enzymes aids in designing new therapeutics against bacterial infections.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- Type II fatty acid synthase is essential for bacterial survival, catalyzing fatty acid chain elongation.
- Individual enzymes and acyl carriers in this pathway are potential targets for antibacterial agents.
Purpose of the Study:
- To highlight the potential of type II fatty acid synthase enzymes as targets for novel antibacterial therapeutics.
- To emphasize the utility of structural data in guiding drug discovery efforts.
Main Methods:
- Review of available high-resolution x-ray and NMR structures of type II fatty acid synthase enzymes.
- Analysis of enzyme roles in pathway regulation and pathway component diversity across human pathogens.
Main Results:
- Structural information for key enzymes in the type II pathway is accessible.
- Understanding enzyme function and pathway variations is crucial for target selection.
Conclusions:
- Structural data of type II fatty acid synthase enzymes provides a foundation for rational drug design.
- Strategic targeting of specific enzymes, considering pathogen diversity, is key for developing effective antibacterial therapies.